Colleen Tupper

CIK: 0001862082

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

COLL

COLLEGIUM PHARMACEUTICAL, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (16 total)

COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2026
Award(A)
Direct
26.4K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2026
Award(A)
Direct
32.7K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2026
Tax Payment(F)
Direct
11.9K shares at avg. $46.75$555K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2026
Tax Payment(F)
Direct
26.7K shares at avg. $46.75$1.2M
COLL
COLLEGIUM PHARMACEUTICAL, INC
Nov 6, 2025
Sale(S)
Direct
25.1K shares at avg. $40.38$1.0M
COLL
COLLEGIUM PHARMACEUTICAL, INC
Nov 6, 2025
Sale(S)
Direct
4.9K shares at avg. $41.28$201K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 21, 2025
Sale(S)
Direct
6.4K shares at avg. $30.03$192K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 20, 2025
Sale(S)
Direct
1.2K shares at avg. $30.00$36K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 14, 2025
Sale(S)
Direct
977 shares at avg. $30.00$29K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 11, 2025
Sale(S)
Direct
10.4K shares at avg. $30.01$313K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 7, 2025
Sale(S)
Direct
1.5K shares at avg. $30.00$45K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 6, 2025
Sale(S)
Direct
1.9K shares at avg. $30.00$58K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2025
Tax Payment(F)
Direct
22.3K shares at avg. $30.52$681K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2025
Award(A)
Direct
51.8K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2025
Award(A)
Direct
27K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2025
Tax Payment(F)
Direct
8.1K shares at avg. $30.52$247K

		Type	Shares	Price		Ownership
Feb 10, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	26,421	-	$0	Direct
Feb 10, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	32,734	-	$0	Direct
Feb 10, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Tax Payment(F)	11,861	$46.75	$554,502	Direct
Feb 10, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Tax Payment(F)	26,679	$46.75	$1,247,243	Direct
Nov 6, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	25,142	$40.38	$1,015,236	Direct
Nov 6, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	4,858	$41.28	$200,517	Direct
Mar 21, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	6,396	$30.03	$192,069	Direct
Mar 20, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	1,206	$30.00	$36,181	Direct
Mar 14, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	977	$30.00	$29,313	Direct
Mar 11, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	10,445	$30.01	$313,413	Direct
Mar 7, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	1,504	$30.00	$45,121	Direct
Mar 6, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	1,949	$30.00	$58,470	Direct
Feb 10, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Tax Payment(F)	22,317	$30.52	$681,115	Direct
Feb 10, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	51,768	-	-	Direct
Feb 10, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	26,957	-	-	Direct
Feb 10, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Tax Payment(F)	8,109	$30.52	$247,487	Direct

1-16 of 16 transactions

About Tupper Colleen

Tupper Colleen (SEC CIK 0001862082) files insider reports with the SEC as EVP & Chief Financial Officer of COLLEGIUM PHARMACEUTICAL, INC (COLL).

Signal8 holds 7 ownership filings by Tupper Colleen, all Form 4s, filed between Feb 12, 2025 and Feb 12, 2026. Those filings report 16 transactions, from Feb 10, 2025 to Feb 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Tupper Colleen's filings is in STOUGHTON, MA.

Recent filings by Tupper Colleen

Feb 10, 2026: Grants or awards of COLL shares (2 lines, Form 4, code A).
Feb 10, 2026: Tax withholdings of COLL shares (2 lines, Form 4, code F).
Nov 6, 2025: Open-market sales of COLL shares (2 lines, Form 4, code S).
Mar 21, 2025: Open-market sale of COLL shares (Form 4, code S).
Mar 20, 2025: Open-market sale of COLL shares (Form 4, code S).

Other insiders filing for COLLEGIUM PHARMACEUTICAL, INC (COLL)

SANTINI GINO, Director
Freund John Gordon, Director
Lurker Nancy, Director
Paya Carlos V, Director
Glancy Donovan Michael, Director
BOHLIN GAREN G, Director

How to read Form 4 transaction codes